By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Merck KGaA 

Frankfurter Street 250

Darmstadt    D-64293  Germany
Phone: 49-6151-720 Fax: 49-6151-722000




SmithKline Beecham 

ChemGenex Pharmaceuticals Limited  Discovery and development collaboration in diabetes and obesity.

GlaxoSmithKline (North Carolina) 

TargeGen, Inc.  Licensing Agreement - Vascular Biology Portfolio.

Company News
Merck KGaA (MKGAF.PK), Darmstadt, Germany, And Pfizer (PFE) To Present Avelumab Data In Seven Different Cancers At ASCO Annual Meeting 5/19/2016 9:40:35 AM
Merck KGaA (MKGAF.PK) Release: Phase III TAILOR Landmark Study Demonstrates Significant Benefits of Erbitux in Combination with FOLFOX Over FOLFOX Alone 4/25/2016 6:36:34 AM
Merck KGaA (MKGAF.PK), Darmstadt, Germany Supports Next Generation Of Scientists At USA Science & Engineering Festival 4/14/2016 9:51:30 AM
R-Biopharm AG And Merck KGaA (MKGAF.PK), Darmstadt, Germany Enter Into Collaboration On Developing And Launching Companion Diagnostics 3/22/2016 9:33:58 AM
BioMed X Innovation Center And Merck KGaA (MKGAF.PK) Extend Collaboration In Cancer Research 3/3/2016 8:35:54 AM
Merck KGaA (MKGAF.PK), Darmstadt, Germany Initiates Phase III Study Of MSB11022, A Proposed Biosimilar Of Adalimumab, In Chronic Plaque Psoriasis 3/2/2016 6:05:00 AM
Threshold Pharma (THLD) And Merck KGaA (MKGAF.PK), Darmstadt, Germany Agree To Key Terms For The Licensing Back Of All Rights To Evofosfamide To Threshold 1/12/2016 12:32:33 PM
Merck KGaA (MKGAF.PK), Darmstadt, Germany, Pfizer (PFE) And Syndax Announce Collaboration To Evaluate Combination Of Avelumab And Entinostat In Ovarian Cancer 1/4/2016 7:46:12 AM
Merck KGaA (MKGAF.PK), Pfizer (PFE) Accelerate Immuno-Oncology Drug Avelumab into Phase III Ovarian and Bladder Cancer Trials 12/22/2015 6:39:29 AM
Struggling Ariad (ARIA) Nets Former Merck KGaA (MKGAF.PK) Exec as New CEO 12/18/2015 6:17:45 AM